Bioprosthetic valves longevity in the pulmonary position in adults with congenital heart disease

Back

ESC Premium Access

Bioprosthetic valves longevity in the pulmonary position in adults with congenital heart disease

Session: Hot topics in treatment of congenital heart disease

Topic: Adult Congenital Heart Disease (ACHD)

Speaker: Doctor A. Egbe (Rochester, US)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Alexander Egbe

Mayo Clinic, Rochester (United States of America)

1 presentation

1 follower

6 more presentations in this session

Safety and efficacy of triple combination therapy with parenteral prostanoids in patients with Eisenmenger physiology

Speaker: Doctor M. D'Alto (Naples, IT)

Access

Abstract

Slides

Oral anticoagulation in 13,344 adult patients with congenital heart disease (ACHD) in a longitudinal real-world setting in 2005-2017

Speaker: Doctor E. Freisinger (Munster, DE)

Access

Abstract

Long term comparison between homograft vs stented bio-prostheses for pulmonary valve replacement in tetralogy of fallot patients

Speaker: Doctor L. cocomello (Bristol, GB)

Access

Abstract

Slides

Transcatheter pulmonary valve implantation versus surgical pulmonary conduit replacement in corrected tetralogy of Fallot with pulmonary atresia: a propensity matched comparison

Speaker: Doctor D. Dorobantu (Bristol, GB)

Access

Abstract

Slides

Influence of restrictive right ventricular physiology in outcomes after transcatheter pulmonary valve implantation in adult patients

Speaker: Doctor A. Francisco (Lisbon, PT)

Access

Abstract

Slides

Access the full session

Hot topics in treatment of congenital heart disease

Speakers: Doctor A. Egbe, Doctor M. D'Alto, Doctor E. Freisinger, Doctor L. cocomello, Doctor D. Dorobantu...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources